MiniMed 780G™ in 2- to 6-Year-Old Children: Safety and Clinical Outcomes After the First 12 Weeks.
Pulkkinen MA, Varimo TJ, Hakonen ET, Harsunen MH, Hyvönen ME, Janér JN, Kiiveri SM, Laakkonen HM, Laakso SM, Wehkalampi K, Hero MT, Miettinen PJ, Tuomaala AK.
Pulkkinen MA, et al. Among authors: varimo tj.
Diabetes Technol Ther. 2023 Feb;25(2):100-107. doi: 10.1089/dia.2022.0313. Epub 2022 Dec 30.
Diabetes Technol Ther. 2023.
PMID: 36511831
Clinical Trial.